The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-2-(5-(4-((1-(2-Fluoro-5-(pyrrolidin-1-yl)phenyl)ethyl)amino)-quinolin-6-yl)pyrimidin-2-yl)propan-2-ol ID: ALA4745102
PubChem CID: 162648827
Max Phase: Preclinical
Molecular Formula: C28H30FN5O
Molecular Weight: 471.58
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C[C@@H](Nc1ccnc2ccc(-c3cnc(C(C)(C)O)nc3)cc12)c1cc(N2CCCC2)ccc1F
Standard InChI: InChI=1S/C28H30FN5O/c1-18(22-15-21(7-8-24(22)29)34-12-4-5-13-34)33-26-10-11-30-25-9-6-19(14-23(25)26)20-16-31-27(32-17-20)28(2,3)35/h6-11,14-18,35H,4-5,12-13H2,1-3H3,(H,30,33)/t18-/m1/s1
Standard InChI Key: VDBAXPLWHOAJIG-GOSISDBHSA-N
Molfile:
RDKit 2D
35 39 0 0 0 0 0 0 0 0999 V2000
7.9779 -8.0316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5735 -7.3258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1645 -8.0290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2850 -6.9207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2856 -6.1035 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9949 -5.6954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6996 -6.1044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6991 -6.9216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9938 -7.3297 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.5330 -4.4719 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2418 -4.8810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2412 -5.6982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5319 -6.1063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8230 -5.6973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1178 -6.1054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4090 -5.6963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4095 -4.8791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1148 -4.4710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8236 -4.8801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5313 -6.9235 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2401 -7.3326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9495 -6.9245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2396 -8.1498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9484 -8.5589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9478 -9.3760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2385 -9.7842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5297 -9.3751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5302 -8.5579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8244 -9.7832 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0774 -9.4483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5291 -10.0544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9372 -10.7638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7357 -10.5936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6536 -8.1507 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.8686 -6.9191 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
4 9 2 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
10 19 1 0
14 19 1 0
21 22 1 6
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
23 28 2 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
29 33 1 0
27 29 1 0
24 34 1 0
21 23 1 0
20 21 1 0
13 20 1 0
7 16 1 0
2 4 1 0
2 35 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 471.58Molecular Weight (Monoisotopic): 471.2434AlogP: 5.83#Rotatable Bonds: 6Polar Surface Area: 74.17Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.36CX Basic pKa: 7.98CX LogP: 4.77CX LogD: 4.17Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.37Np Likeness Score: -1.10
References 1. Xiao HY,Li N,Duan JJ,Jiang B,Lu Z,Ngu K,Tino J,Kopcho LM,Lu H,Chen J,Tebben AJ,Sheriff S,Chang CY,Yanchunas J,Calambur D,Gao M,Shuster DJ,Susulic V,Xie JH,Guarino VR,Wu DR,Gregor KR,Goldstine CB,Hynes J,Macor JE,Salter-Cid L,Burke JR,Shaw PJ,Dhar TGM. (2020) Biologic-like In Vivo Efficacy with Small Molecule Inhibitors of TNFα Identified Using Scaffold Hopping and Structure-Based Drug Design Approaches., 63 (23): [PMID:33261314 ] [10.1021/acs.jmedchem.0c01732 ]